Skip to main content
. Author manuscript; available in PMC: 2010 Oct 1.
Published in final edited form as: Arch Neurol. 2009 Oct;66(10):1247–1253. doi: 10.1001/archneurol.2009.207

Table 4.

Mean Differences (95% CI) in Cognitive Decline*, by Percent Change over Ten Years in Plasma Amyloid β Measures

COGNITIVE TEST TICS GLOBAL SCORE VERBAL SCORE
Amyloid β 40:42 Ratio
    Age/education-adjusted −0.08 (−0.15, −0.01) −0.02 (−0.04, −0.00) −0.02 (−0.04, 0.01)
    p-trend 0.02 0.03 0.16
    Multivariable-adjusted −0.08 (−0.15, −0.01) −0.02 (−0.04, −0.00) −0.02 (−0.04, 0.01)
    p-trend 0.02 0.03 0.18

Amyloid β 42
    Age/education-adjusted 0.03 (−0.03, 0.10) 0.01 (−0.01, 0.02) −0.00 (−0.03, 0.02)
    p-trend 0.32 0.56 0.67
    Multivariable-adjusted 0.04 (−0.03, 0.11) 0.01 (−0.01, 0.02) −0.01 (−0.03, 0.02)
    p-trend 0.31 0.57 0.65
*

Mean (range) cognitive testing interval was 4.1 (3.1 − 5.5) years.

Linear trend for each SD increase in percent change of Aβ−40:Aβ−42 ratio or Aβ−42. Mean (range) interval between first and second plasma collection was 11.1 (9.2 − 12.2) years.

Models adjusted for age at baseline interview and education; cigarette smoking, postmenopausal hormone use, hypertension, elevated cholesterol, body mass index, alcohol intake and physical activity level as of blood draw; and depression status as of start of cognitive testing.